Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma

Maurizio Battaglia Parodi, Pierluigi Iacono

Research output: Contribution to journalArticle

Abstract

Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.

Original languageEnglish
Pages (from-to)157-158
Number of pages2
JournalAmerican Journal of Ophthalmology
Volume138
Issue number1
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Neovascular Glaucoma
Photochemotherapy
Iris
Intraocular Pressure
Contact Lenses
Macular Degeneration
Anterior Chamber
Lasers
Outcome Assessment (Health Care)
verteporfin

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. / Parodi, Maurizio Battaglia; Iacono, Pierluigi.

In: American Journal of Ophthalmology, Vol. 138, No. 1, 07.2004, p. 157-158.

Research output: Contribution to journalArticle

@article{ccac51d5804e40b489953496085bb879,
title = "Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma",
abstract = "Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.",
author = "Parodi, {Maurizio Battaglia} and Pierluigi Iacono",
year = "2004",
month = "7",
doi = "10.1016/j.ajo.2004.02.015",
language = "English",
volume = "138",
pages = "157--158",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma

AU - Parodi, Maurizio Battaglia

AU - Iacono, Pierluigi

PY - 2004/7

Y1 - 2004/7

N2 - Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.

AB - Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.

UR - http://www.scopus.com/inward/record.url?scp=3042784822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042784822&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.02.015

DO - 10.1016/j.ajo.2004.02.015

M3 - Article

C2 - 15234305

AN - SCOPUS:3042784822

VL - 138

SP - 157

EP - 158

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 1

ER -